Related Experiment Video
Updated: Jan 28, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Effect of risperidone on proliferation and apoptosis of MC3T3-E1 cells
Lei Zheng1,2, Lixia Yang2, Xin Zhao3
1Department of Mental Health and Psychiatry, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Abstract:
This aim of this study was to assess the molecular mechanism of osteoporosis in schizophrenia patients with risperidone use. Here, we investigated the effects of risperidone on cellular proliferation and apoptosis of a preosteoblast cell line, MC3T3-E1. Cell viability and apoptotic rate of MC3T3-E1 were detected by cell counting kit-8 and flow cytometry at a serial dose of risperidone and at different time points, respectively. Bone transformation relevant gene serum osteocalcin (BGP), collagen 1, tumor necrosis factor-α (TNF-α), osteoprotegerin (OPG), and receptor activator of nuclear factor-κB ligand (RANKL) mRNA levels were determined by real-time PCR (qPCR). Their protein expression patterns were evaluated using western blot. The results revealed that risperidone dramatically inhibited MC3T3-E1 cell proliferation in a dose-dependent manner. It also significantly induced MC3T3-E1 cell apoptosis. TNF-α gene and protein levels were greatly enhanced after risperidone treatment. In contrast, BGP, collagen 1, OPG, and RANKL gene and protein levels were markedly downregulated. Our study indicated that risperidone suppressed MC3T3-E1 cell proliferation and induced apoptosis. It also regulated BGP gene and protein expression.
Insights
Risperidone use in schizophrenia patients may increase osteoporosis risk by inhibiting preosteoblast cell proliferation and inducing apoptosis. This antipsychotic medication affects key bone metabolism genes, including osteocalcin (BGP).
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Schizophrenia treatment often involves antipsychotics like risperidone.
- Osteoporosis is a potential side effect linked to risperidone use.
- The molecular mechanisms underlying this association require elucidation.
Purpose of the Study:
- To investigate the molecular mechanisms of osteoporosis in schizophrenia patients using risperidone.
- To assess the effects of risperidone on preosteoblast cell proliferation and apoptosis.
Main Methods:
- Utilized MC3T3-E1 preosteoblast cell line.
- Assessed cell viability and apoptosis using cell counting kit-8 and flow cytometry.
- Quantified mRNA and protein expression of bone metabolism markers (BGP, collagen 1, TNF-α, OPG, RANKL) via qPCR and Western blot.
Main Results:
- Risperidone significantly inhibited MC3T3-E1 cell proliferation in a dose-dependent manner.
- Risperidone treatment markedly induced apoptosis in MC3T3-E1 cells.
- Downregulation of BGP, collagen 1, OPG, and RANKL, with increased TNF-α expression observed.
Conclusions:
- Risperidone suppresses preosteoblast proliferation and promotes apoptosis.
- The drug alters the expression of critical genes involved in bone metabolism.
- Findings suggest a molecular basis for risperidone-associated osteoporosis.
Related Concept Videos
Apoptosis
Cells Coordinate Growth and Proliferation
E1 Reaction: Kinetics and Mechanism
E1 Reaction: Stereochemistry and Regiochemistry
Abnormal Proliferation
Adult Stem Cells

